Co-Infection
32307254 ä. Invasive fungal diseases during COVID-19: We should be prepared
32297939 ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise
32293646 ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens
32192233 2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus
32170625 ä. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients
32305630 ä. A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens
32173883 ä. COVID?19 and mycoplasma pneumoniae coinfection
32314699 2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic
32271596 2020. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran
| 32374823 2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |
32379863 ä. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization
32301747 2020. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children
32292053 2020. Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report
32362302 ä. To alert coinfection of COVID-19 and dengue virus in developing countries in the dengue-endemic area
32378044 ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
| 32265235 2020. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case |
32196707 ä. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China
32352574 2020. Co-infection in SARS-CoV-2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus?
32320082 2020. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia
32293743 2020. Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated
32344469 2020. DIC in COVID-19: Implications for Prognosis and Treatment?
32267998 2020. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series
